Biotechnology 5 January 2026

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded.

9 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology shares jumped on Friday after the company moved up the expected timing for late-stage trial results in bladder cancer. The stock was up 25.1% at $52.45 by 11:52 EST, versus Thursday’s close of $41.93, after trading between $41.63 and $52.64 on the day as volume topped 4.1 million shares.

9 January 2026

Biotechnology·NASDAQ:CGOI·Pharmaceutical News·Stock Market

Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

Eli Lilly and Company shares were down about 0.4% at $1,081 in morning trade on Friday. The drugmaker said this week it will buy autoimmune developer Ventyx Biosciences for $1.2 billion in cash, bringing oral candidates for inflammatory bowel disease into its pipeline. The $14-a-share offer is slated to close in the first half of 2026, and Cantor Fitzgerald analyst Carter Gould described the price as “borderline immaterial” for Lilly.

9 January 2026

Biotechnology·NYSE:LLY·Pharmaceuticals·Stock Market

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

MoonLake Immunotherapeutics shares jumped 27% to $14.34 on Thursday after the biotech said U.S. regulators supported a route to file its hidradenitis suppurativa treatment without doing more trials for the skin disease. The stock churned between $11.20 and $17.28, and roughly 24 million shares traded.

8 January 2026

Biotechnology·NASDAQ:MLTX·Pharmaceuticals·Stock Market

Merck stock climbs on Wolfe upgrade as Cidara deal closes and Gardasil questions linger

Merck & Co shares rose 1.5% to $110.20 in afternoon trading on Thursday after Wolfe Research upgraded the drugmaker, outpacing a softer health-care sector. The stock traded as high as $112.08 and as low as $107.94, while AbbVie slid about 3.9% and the S&P 500 ETF was little changed.

8 January 2026

Biotechnology·NASDAQ:CDTX·NYSE:MRK·Pharmaceuticals·Stock Market

Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Shares of Immuneering Corp jumped about 24% to $8.33 in premarket trading on Thursday, after the biotech released updated survival data for its lead pancreatic cancer program. The stock last closed at $6.74.

8 January 2026

Biotechnology·NASDAQ:IMRX·Pharmaceutical News·Stock Market

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

Amgen shares rose 3.5% to $341.64 in Wednesday’s regular session and were last near that level after the bell. UBS assumed coverage with a buy rating and a $380 price target, saying it sees “upside from EPS and pipeline.”

8 January 2026

Biotechnology·NASDAQ:AMGN·NYSE:AMRX·Stock Market

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

Thermo Fisher Scientific shares slipped about 0.6% in after-hours trading on Wednesday to $617.15, after swinging between $611.93 and $626.40 during the session.

8 January 2026

Biotechnology·Earnings Reports·NYSE:TMO·Stock Market

Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

Viasat shares fell $4.89, or about 11.3%, to $38.57 on Wednesday, a day after the stock closed at $43.46. The shares traded between $38.27 and $43.58.

7 January 2026

Biotechnology·LSE:ISAT·NASDAQ:VSAT·Pharmaceuticals·Stock Market

Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

Wave Life Sciences shares rose 4.4% to $15.82 in midday trade on Wednesday. The stock has stayed in motion as investors circle back to obesity plays tied to a gene target called INHBE.

7 January 2026

Biotechnology·NASDAQ:ARWR·NASDAQ:WVE·Stock Market

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks.

7 January 2026

Biotechnology·NASDAQ:ADPT·Stock Market

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Shares of Structure Therapeutics Inc rose 5.6% to $66.75 in late-morning trade on Wednesday, recovering from early swings as investors sized up a newly disclosed patent license deal tied to Roche and Genentech’s oral obesity drug effort.

7 January 2026

Biotechnology·NASDAQ:GPX

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

Pfizer shares rose about 0.9% to $25.67 in morning trade on Wednesday, even as investors weighed a new patent lawsuit tied to its COVID-19 vaccine and a cautious call from UBS.

7 January 2026

Biotechnology·NASDAQ:BNTX·NASDAQ:MRNA·NYSE:PFE·XETRA:BAYN

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience Holdings Ltd shares rose 18.3% to $31.99 on Tuesday, after touching $34.40 earlier and sliding as low as $26.60. The Nasdaq-listed stock was last up $4.95 from Monday’s close of $27.04, with about 850,000 shares traded.

6 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up

Wave Life Sciences Ltd shares jumped about 17% on Tuesday, extending sharp swings in the obesity drug trade as investors sized up the next set of clinical readouts.

6 January 2026

Biotechnology·NASDAQ:WVE·Stock Market

Arrowhead stock leaps after gene-silencing obesity drug doubles Lilly’s Zepbound weight loss

Arrowhead Pharmaceuticals shares rose about 16% on Tuesday after early clinical data showed its experimental gene-silencing obesity drug boosted weight loss when used alongside Eli Lilly’s tirzepatide, sold as Zepbound. The stock was up 16% at $74.13 in midday trading, after swinging between $62.17 and $76.32. Investors.com

6 January 2026

Biotechnology·NASDAQ:ARWR·NYSE:LLY·Pharmaceuticals

Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next

Cyclerion Therapeutics Inc shares jumped about 46% to around $2.01 in premarket trading on Tuesday after the company announced an expanded strategic collaboration with Medsteer to advance its closed-loop anesthetic platform, CYC-126. Benzinga

6 January 2026

Biotechnology·NASDAQ:CYCN·Stock Market

GSK stock rises after Japan greenlights twice-yearly Exdensur for severe asthma, nasal polyps

GSK plc shares rose nearly 1% in early London trade on Tuesday after the drugmaker said Japan had approved its bronchial asthma treatment Exdensur. Shares were up 0.96% at 1,838 pence by 0830 GMT. sharecast.com

6 January 2026

Biotechnology·LSE:GSK·Stock Market

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific Inc shares rose about 2.4% in afternoon trading on Monday after Evercore ISI raised its price target to $650 from $610 and kept an “outperform” rating, a call that signals expectations for the stock to beat the broader market. The stock was last up 2.4% at $606.63, after swinging between $590.00 and $608.29 on volume of about 1.6 million shares. MarketScreener

5 January 2026

Biotechnology·Earnings Reports·NYSE:TMO·Stock Market

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline in the SPDR S&P Biotech ETF, a broad gauge of U.S. biotech stocks.

5 January 2026

Biotechnology·NASDAQ:BBIO·Stock Market

Biotechnology 5 January 2026 - 9 January 2026